← SynDRA
EPZ-004777
SynDRA canonical compound SYN0078926 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | DOT1L |
|---|
| Mechanism of action | histone lysine methyltransferase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- histone lysine methyltransferase inhibitor
- DOT1L INHIBITOR
Cross-references
Synonyms
- EPZ004777
- DOT1L inhibitors (mixed lineage leukemia)
- DOT1L inhibitors (leukemia), Epizyme/GSK
- DOT1L inhibitors (mixed lineage leukemia), Epizyme/GlaxoSmithKline
- Epz004777
- EPZ 004777
- RefChem:921077
- MFCD25563264
- WXRGFPHDRFQODR-ICLZECGLSA-N
- C28H41N7O4
- 0QK
- GTPL7377
- SCHEMBL9274416
- CHEBI:124920
- EX-A1764
- BDBM50396023
- NSC775852
- NSC780043
- s7353
- AKOS022185751
- CCG-269958
- EBC-515475
- EPZ004777?
- NSC-775852
- NSC-780043
- NCGC00356803-03
- NCGC00356803-07
- NCGC00356803-12
- AC-27388
- BE162783
- HY-15227
- E6298
- SW219207-1
- C72346
- BRD-K69070623-001-01-1
- BRD-K69070623-001-02-9
- BRD-K69070623-003-01-7
- 7-[5-Deoxy-5-[[3-[[[[4-(1,1-dimethylethyl)phenyl]amino]carbonyl]amino]propyl](1-methylethyl)amino]-beta-D-ribofuranosyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Look up EPZ-004777 in the interactive SynDRA portal →